Lymphedema Surveillance Study

Status:	Recruiting
Conditions:	Breast Cancer, Breast Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	6/29/2018
Start Date:	April 2016
End Date:	April 2019
Contact:	Andrea Barrio, MD
Phone:	646-888-5117

A Prospective Surveillance Program for Assessment and Treatment of Breast Cancer-Related Lymphedema After Axillary Lymph Node Dissection

This study is being done to find out how many women develop lymphedema after an axillary
lymph node dissection. The investigators also want to look for reasons why some women get
lymphedema and others don't. Specifically, the investigators want to do tests on the breast
tissue that is removed at the time of surgery to see if they can identify inflammation in the
breast tissue, which may increase a woman's risk for lymphedema. The investigators will also
ask the patient to answer questions to see how much their quality of life is affected by
lymphedema, and whether this study can help women by detecting lymphedema earlier.

Inclusion Criteria:

- Female breast cancer patients over the age of 18

- Patients consenting for unilateral axillary lymph node dissection (ALND) (prior
history of sentinel lymph node biopsy allowed if <6 months from consent)

- Patients consenting for unilateral sentinel lymph node biopsy (SLNB) and possible ALND
are eligible for initial entry into the study, but will become ineligible if ALND is
not performed

Exclusion Criteria:

- Male breast cancer patients

- Patients treated with SLNB only

- Patients consenting for bilateral axillary surgery

- Patients with prior history of surgical excision of one or more axillary lymph nodes
or SLNB, performed >6 months from date of consent

- Patients with prior history of ALND

- Patients with no breast surgery performed at MSK

We found this trial at

sites

Memorial Sloan Kettering Cancer Center

1275 York Ave
New York, New York 10021

(212) 639-2000